Recent Posts

Oracle wins shares needed to clinch $9bn NetSuite buy

  Bloomberg NetSuite Inc. shareholders endorsed Oracle Corp.’s bid for the software provider, clearing the path for the $9 billion acquisition after weeks of conflict between a large investor and executives over the price tag. The deal received approval from 53 percent, or 21.78 million shares, of NetSuite stockholders that were eligible to endorse the bid, Oracle said in a ...

Read More »

Nestle pays $145mn for stake in biotech firm Aimmune

  Bloomberg Nestle SA’s health unit is investing $145 million for a 15 percent stake in Aimmune Therapeutics Inc., a California maker of food-allergy therapies. Nestle Health Science, a subsidiary of the Swiss food giant, will pay $19.20 a share for about 7.55 million newly issued shares of Aimmune, and the unit’s Chief Executive Officer Greg Behar will join the ...

Read More »

Dow-DuPont beset by delays as EU demands missing deal info

  Bloomberg Dow Chemical Co. and DuPont Co. face further delays to their plan to create the world’s biggest chemical company after the European Commission demanded more information about the $59 billion tie-up. The European Union’s merger regulator “stopped the clock” in its in-depth investigation on Oct. 13, the watchdog said in an e-mail on Friday. This happens “if the ...

Read More »
Send this to a friend